Medicare Advantage Appeal Letter Template 2026: 5-Level MA Guide

Understanding Medicare Advantage Appeals in 2026

Medicare Advantage (Part C) appeals follow a separate 5-level process from Original Medicare. When your MA plan denies a claim or prior authorization, federal regulations under 42 CFR Part 422, Subpart M give you appeal rights at each level — up to federal district court.

The process matters more than ever in 2026. According to KFF data, MA insurers made nearly 53 million prior authorization determinations in 2024, and a 2026 analysis found MA prior authorization denial rates jumped 56% over recent years. Two major CMS rules that took effect this year directly affect how you appeal and what plans are required to tell you.

Independent practices treating Medicare Advantage patients need current templates, current deadlines, and awareness of these regulatory changes. The templates and timelines in this guide reflect 2026 CMS rules — see our 2025 version for prior-year context.

What Changed for Medicare Advantage Appeals in 2026

CMS-0057-F: Prior Authorization Rule (Effective January 1, 2026)

The CMS Interoperability and Prior Authorization Final Rule took effect January 1, 2026 for MA plans. The two most practice-relevant changes:

1. Standard PA decisions now 7 calendar days (down from 14) MA plans must now issue standard (non-urgent) prior authorization decisions within 7 calendar days of receiving the request, under 42 CFR § 422.568. Expedited PA requests remain 72 hours. If a plan misses these timelines, document it — a procedural violation can strengthen your appeal or trigger a complaint to your State Insurance Commissioner.

2. Plans must now state specific clinical denial reasons Plans can no longer issue vague "not medically necessary" denials. Each PA denial must now identify the specific clinical criterion used and state explicitly why the criterion was not met. This is a major shift for appeals: quote the stated criterion verbatim in your appeal letter, then address it point-by-point with your clinical documentation.

3. Public PA metrics reporting by March 31, 2026 MA plans must post approval rates, denial rates, and appeal outcomes publicly on their websites. Practices can use this data to benchmark how aggressively a specific plan is denying and to understand which services see higher overturn rates.

CMS-4208-F: CY 2026 Final Rule Changes

This rule, published April 15, 2025 in the Federal Register, made several changes affecting appeal rights:

• Concurrent determinations are now organization determinations. Denials of continued inpatient stays or mid-service coverage changes now explicitly trigger the full 5-level appeal process under 42 CFR § 422.566.
• Retroactive reversals of approved inpatient admissions are prohibited except for fraud or obvious error. If your plan approved an admission, they cannot later reverse that determination on medical necessity grounds after the patient has been discharged.
• Provider notification requirements expanded. Plans must notify the treating provider — not just the enrollee — when a coverage decision is made on a request submitted by a provider on the enrollee's behalf.

Updated AIC Thresholds for 2026

Amount in Controversy (AIC) thresholds are adjusted annually. For CY 2026 (per the December 4, 2025 Federal Register adjustment):

• Level 3 ALJ Hearing: $200 (up from $190 in 2025)
• Level 5 Federal District Court: $1,960 (up from $1,900 in 2025)

The 5-Level Medicare Advantage Appeal Process

Key process note: If your MA plan upholds the denial at Level 1, they are required by law (42 CFR § 422.590) to automatically forward your case to the IRE (Level 2) for independent review. You do not need to file a separate Level 2 request — the forwarding is mandatory. The IRE contractor for MA Part C is MAXIMUS Federal Services, which operates independently from your MA plan.

Medicare Advantage Appeal Letter Template (Standard — Level 1)

Use this template for standard (non-urgent) Medicare Advantage reconsideration requests submitted directly to your MA plan. Submit within 65 days of the denial notice date pursuant to 42 CFR § 422.582.

[Your Practice Letterhead]

[Date]

[Medicare Advantage Plan Name]
Appeals Department
[Address from denial notice]

RE: Request for Reconsideration (Level 1 Appeal)
Member Name: [Full Name]
Medicare Beneficiary Identifier (MBI): [11-character Medicare ID]
MA Plan Member ID: [Plan-specific ID]
Date of Birth: [MM/DD/YYYY]
Claim / Authorization Number: [From denial notice]
Date(s) of Service: [Service date or range]
Provider NPI: [NPI number]
Provider Name: [Practice name]
Service Denied: [Brief description]
CPT / HCPCS Code(s): [Codes]
Primary Diagnosis (ICD-10): [Code and description]
Date of Denial Notice: [Date]
Reason for Denial (verbatim): "[Quote the exact denial language]"

Dear [MA Plan Name] Appeals Review Team:

I am writing to formally request reconsideration of the denial described
above pursuant to 42 CFR § 422.582. This appeal is submitted within the
65-day filing deadline.

DENIAL REASON — SPECIFIC REBUTTAL

[MA Plan Name] denied this service citing: "[quote the specific clinical
criterion and reason from the denial notice — per CMS-0057-F, effective
January 1, 2026, MA plans must now state specific clinical reasons for
PA denials]."

I respectfully disagree with this determination for the following reasons:

[Address the specific criterion the plan cited. Do not address generic
"medical necessity" broadly — respond directly to the stated criterion.]

PATIENT CLINICAL PRESENTATION

[Member name] is a [age]-year-old Medicare Advantage beneficiary
diagnosed with [primary diagnosis — ICD-10 code]. Clinical presentation:

Medical History:
- [Relevant diagnosis with onset date]
- [Comorbidities affecting treatment decisions]
- [Previous treatments attempted and outcomes]

Current Clinical Status:
- [Objective findings: labs, vitals, exam, imaging with dates and values]
- [Functional limitations with measurements — use validated scales]
- [Symptom severity with objective measures]

MEDICAL NECESSITY JUSTIFICATION

1. Evidence-Based Indication
[Service] is the standard of care for [condition] per [medical society]
clinical practice guidelines ([year], [guideline title]).

2. Medicare Coverage Compliance
This service meets criteria in [NCD number or LCD L-number for your MAC
region]. Specifically:
- Coverage criterion 1: [How patient meets it]
- Coverage criterion 2: [How patient meets it]

3. Failed Conservative Treatment (if applicable)
The following less intensive treatments were attempted prior to this
request without adequate clinical response:
- [Treatment 1]: [Dates, dosage/duration, outcome]
- [Treatment 2]: [Dates, dosage/duration, outcome]

SUPPORTING DOCUMENTATION

The following documentation supports this reconsideration:
- Clinical notes from [date range]
- [Diagnostic study] results dated [date]
- Treating physician letter of medical necessity
- [Failed treatment records if applicable]
- [Relevant guideline excerpts]
- Copy of original denial notice

REQUESTED RELIEF

I respectfully request that [MA Plan Name] overturn this denial and
approve / pay [service] for [member name]. If [MA Plan Name] upholds
this denial, I understand the case will be automatically forwarded to
the Independent Review Entity (IRE) pursuant to 42 CFR § 422.590.

Sincerely,

[Physician Name], [Credentials]
[Medical License Number]
[NPI Number]
[Practice Name, Address, Phone, Fax]

Enclosures: [List all attached documents]
CC: [Patient name]

Medicare Advantage Expedited Appeal Template (72-Hour Review)

Request expedited review only when waiting for the standard 30-day timeline would seriously jeopardize the beneficiary's life, health, or ability to regain maximum function. Per 42 CFR § 422.584, the plan must decide within 72 hours.

[Your Practice Letterhead]

[Date and Time Submitted]

[MA Plan Name] — EXPEDITED APPEALS UNIT
[Expedited fax number or address from plan documents]

EXPEDITED APPEAL — 72-HOUR REVIEW REQUIRED
(42 CFR § 422.584)

Member Name: [Full Name]
MBI: [Number]
MA Plan Member ID: [Number]
Claim / Authorization Number: [Number]
Date(s) of Service: [Date or upcoming service date]
Service Denied: [Description]
Date of Denial: [Date]

CLINICAL URGENCY — WHY EXPEDITED REVIEW APPLIES

[Member name] requires [denied service] on an urgent basis. Applying
the standard 30-day timeline would seriously jeopardize this
beneficiary's [life / health / ability to regain maximum function]
for the following clinical reasons:

Immediate Health Risk:
- [Specific, measurable risk — e.g., "O2 saturation 87% on room air
  with rapid progression; delay of 30 days risks respiratory failure"]
- [Cite objective values, not subjective statements]

Physician Certification of Urgency:
[Physician name], treating physician, certifies that immediate
intervention is required because [brief clinical statement].

[Follow the standard template structure for Clinical Presentation,
Medical Necessity Justification, and Supporting Documentation.]

If [MA Plan Name] upholds this denial, I understand that the case will
be automatically forwarded to the IRE for expedited Level 2 review
(72 hours) pursuant to 42 CFR § 422.590.

[Signature block]
[Submission method: fax with timestamp, portal with confirmation ID]

What to Include in Your MA Appeal Package

Each appeal submission should include these components organized with a cover page listing each enclosure:

Required:

• Completed appeal letter (using template above)
• Copy of the denial notice (organization determination)
• Clinical notes for the relevant episode of care
• Treating physician letter of medical necessity addressing the denial reason specifically
• Diagnostic results supporting medical necessity (labs, imaging reports)

Strongly recommended:

• Failed treatment documentation (dates, doses, outcomes)
• Clinical practice guideline excerpts with the relevant recommendation highlighted
• Medicare NCD or LCD citation for your MAC region (find LCDs at cms.gov/medicare/coverage/lcd-database)
• For concurrent/mid-service denials: copy of the original prior authorization approval (protected from retroactive reversal under CMS-4208-F)

For expedited appeals, also include:

• Physician statement certifying urgency and specific health risk from delay
• Documentation of rapid disease progression or severe current symptoms

Submission Methods

Most MA plans accept appeals by fax, online portal, or certified mail. Always obtain a confirmation — fax confirmation report, portal submission ID, or USPS certified mail receipt. The deadline runs from the date on the denial notice; proof of timely submission matters if timing is questioned.

Common Mistakes That Hurt MA Appeals

Missing the 65-day deadline. Count from the date printed on the denial notice, not the date you received it. Late appeals are rejected regardless of clinical merit — no exceptions except documented extraordinary circumstances.

Ignoring the specific denial criterion. Since January 1, 2026, plans must state the specific clinical criterion they applied and why the patient didn't meet it. Your appeal must address that specific criterion directly. A generic medical necessity argument that doesn't rebut the stated criterion is easier to uphold.

No objective clinical measurements. "Patient is worse" doesn't persuade a reviewer. Use lab values, imaging findings, functional test scores, validated outcome measures (PHQ-9, VAS, ROM measurements), and specific dates.

Missing failed treatment documentation. Many MA services require documented failure of conservative treatment. List each prior treatment with: specific medication or therapy, dates, dosages or intensity, and the objective reason it failed (insufficient response, adverse effect, contraindication).

Confusing MA appeals with Original Medicare. If the patient has a Medicare Advantage plan, appeal to the MA plan — not to your Medicare Administrative Contractor (MAC). The processes are entirely separate. An appeal sent to the wrong entity misses the deadline even if it arrives on time.

Not citing the NCD or LCD. Medicare has National and Local Coverage Determinations for many services. Citing the applicable coverage determination and showing the patient meets its criteria is the most efficient way to demonstrate Medicare-covered medical necessity.

How Muni Appeals Helps With Medicare Advantage Denials

Medicare Advantage denials require insurer-specific knowledge — each plan (UnitedHealthcare, Humana, Aetna, BCBS, Cigna) applies slightly different coverage criteria and processes appeals through different submission channels. The 2026 regulatory changes add another layer: appeals now need to address specific plan-stated denial criteria, reference the applicable NCD/LCD, and account for new CMS-4208-F protections where relevant.

Muni Appeals organizes this workflow for billing teams:

• Tracks the 65-day filing deadline automatically from the denial date
• Identifies whether a case has expedited review criteria
• Compiles NCD/LCD references for the MAC region based on the procedure code
• Monitors automatic IRE forwarding after Level 1 decisions
• Keeps submission records for each plan's appeal channel

For practices with significant Medicare Advantage volume, systematic appeal tracking reduces the administrative burden of managing 30-day and 72-hour decision windows across multiple plans simultaneously.

Start 3 Free Appeals →

Frequently Asked Questions

What is the deadline to appeal a Medicare Advantage denial in 2026?

The Level 1 reconsideration deadline is 65 calendar days from the date on the denial notice, pursuant to 42 CFR § 422.582. Count from the date printed on the notice, not the date you received it. For expedited appeals (when delay would seriously harm the patient), call your MA plan immediately — you can request expedited review verbally, then follow up in writing.

What changed about Medicare Advantage appeals for 2026?

Two major changes. First, under CMS-0057-F (effective January 1, 2026), standard prior authorization decisions must now be issued within 7 calendar days (down from 14), and plans must state specific clinical denial reasons — not just "not medically necessary." Second, under CMS-4208-F, concurrent (mid-service) coverage denials now explicitly trigger the full appeal process, and plans are prohibited from retroactively reversing approved inpatient admissions except for fraud or obvious error.

What is the Level 2 IRE and do I have to request it separately?

The Level 2 IRE (Independent Review Entity) is an independent review conducted by MAXIMUS Federal Services, a contractor that is not affiliated with your MA plan. If your MA plan upholds a Level 1 denial (in whole or in part), they are required by 42 CFR § 422.590 to automatically forward your case to the IRE — you do not need to file a separate request. You can submit additional evidence directly to the IRE during their review.

What is the ALJ threshold for Medicare Advantage in 2026?

The Amount in Controversy (AIC) threshold for requesting a Level 3 Administrative Law Judge (ALJ) hearing is $200 for CY 2026, adjusted up from $190 in 2025. The Federal District Court threshold (Level 5) is $1,960 for 2026. These thresholds are adjusted annually per the Federal Register. If your denied claim does not meet the ALJ threshold, your appeal effectively concludes at Level 2 (IRE).

How do I appeal a concurrent service denial (mid-stay) in 2026?

Concurrent denials — such as plans terminating coverage of an ongoing inpatient hospital stay or skilled nursing facility stay — are now explicitly organization determinations under CMS-4208-F, triggering the full 5-level appeal process. For a Notice of Medicare Non-Coverage (NOMNC) during inpatient stay, expedited appeal rights apply: the plan and IRE must decide within 72 hours. If your plan issued a concurrent denial while an admission was already approved, note that CMS-4208-F prohibits retroactive reversal of the original approval except for fraud or obvious error.

Can I appeal a post-service claim denial as well as pre-service prior auth denials?

Yes. Both pre-service (prior authorization denied before service) and post-service (claim denied after service rendered) decisions are organization determinations appealable through the 5-level process. Post-service claims have a standard 30-day plan decision window. The 65-day filing deadline applies from the adverse determination notice, whether it is a PA denial or a claim payment denial.

What documentation matters most for a strong MA appeal?

The treating physician's letter of medical necessity is the single most important document. It must directly address the plan's specific denial reason (required to be stated per CMS-0057-F in 2026), cite applicable NCD/LCD criteria, and document any failed conservative treatments with objective outcomes. Pair the physician letter with complete clinical notes, diagnostic results, and — if relevant — clinical guideline excerpts from the relevant specialty society. Organize all documents with a cover page listing each enclosure.

Where can I find more information on MA appeal deadlines by plan?

See our Medicare Advantage timely filing guide for Humana for Humana-specific MA deadlines. For the broader insurance appeal deadline framework across all levels and plan types, see our insurance appeal deadlines guide. For the IRE and external review process in more detail, see our independent review organization guide.

Ready to Systematize Your Medicare Advantage Appeals?

Medicare Advantage denials are rising. The regulatory changes in 2026 give practices new tools to challenge them — but only if you use them. That means quoting the specific denial criterion in your appeal letter, submitting within 65 days, and knowing when the automatic IRE forwarding applies.

Muni Appeals manages the tracking and documentation workflow so billing teams can focus on the clinical argument rather than the administrative logistics.

Get started:

• Submit your first 3 Medicare Advantage appeals free
• Track deadlines and IRE forwarding across all MA plans
• Access plan-specific appeal channels (UHC, Humana, Aetna, BCBS, Cigna MA)
• Reference current NCD/LCD criteria by MAC region

Start 3 Free Appeals →

---

This guide reflects 2026 Medicare Advantage appeal procedures under 42 CFR Part 422, Subpart M, including CMS-0057-F (effective January 1, 2026) and CMS-4208-F (CY 2026 Final Rule). AIC thresholds reflect the December 4, 2025 Federal Register adjustment. State requirements and specific MA plan details may vary. This information is for administrative and billing purposes and is not medical advice.